Catalyzing Change: Assessing Inner Setting Context of Cervical Cancer Prevention Efforts in Loreto, Peru, Prior to Transition from VIA to HPV Screen-and-Treat.

HPV Inner setting Peru cervical cancer

Journal

Research square
ISSN: 2693-5015
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
27 Sep 2024
Historique:
pubmed: 14 10 2024
medline: 14 10 2024
entrez: 14 10 2024
Statut: epublish

Résumé

The objective of this study was to understand health care providers' perspectives regarding the facilitators of and barriers to the success of the former Pap and VIA-based cervical cancer program in Iquitos, Peru, using the Consolidated Framework for Implementation Research (CFIR) to inform the transition to the HPV screen-and-treat intervention. By exploring the pre-implementation organizational context, or inner setting, through the opinions of those who would implement the HPV-based intervention at the patient care level, this research lays the foundation to assess readiness before implementation and understand what's necessary to design contextually appropriate and sustainable interventions in LMIC settings. We conducted 19 semi-structured interviews with health professionals (12 nurse-midwives, 4 doctors, and 3 laboratory technicians) who administered the former Pap- and VIA-based cervical cancer EDT program. Providers identified information gaps between the primary level of care, where cervical cancer screening occurs, and the hospital level of care, where diagnosis and treatment occurs. These gaps, which were caused in part by fragmented, antiquated, and overlapping data systems, resulted in the loss of patients between levels of care. Participants also noted a lack of trained personnel and basic materials. Some providers found their way around these gaps by facilitating informal information exchanges among providers to ensure women were not lost to follow-up. PPC relied on these findings and other data from INSPIRE Phase 1 to implement a HPV-based screen-and-treat program that dramatically increased screening and treatment; however, challenges remain regarding resources and sustainability related to HPV technology.

Sections du résumé

Background UNASSIGNED
The objective of this study was to understand health care providers' perspectives regarding the facilitators of and barriers to the success of the former Pap and VIA-based cervical cancer program in Iquitos, Peru, using the Consolidated Framework for Implementation Research (CFIR) to inform the transition to the HPV screen-and-treat intervention. By exploring the pre-implementation organizational context, or inner setting, through the opinions of those who would implement the HPV-based intervention at the patient care level, this research lays the foundation to assess readiness before implementation and understand what's necessary to design contextually appropriate and sustainable interventions in LMIC settings.
Methods UNASSIGNED
We conducted 19 semi-structured interviews with health professionals (12 nurse-midwives, 4 doctors, and 3 laboratory technicians) who administered the former Pap- and VIA-based cervical cancer EDT program.
Results UNASSIGNED
Providers identified information gaps between the primary level of care, where cervical cancer screening occurs, and the hospital level of care, where diagnosis and treatment occurs. These gaps, which were caused in part by fragmented, antiquated, and overlapping data systems, resulted in the loss of patients between levels of care. Participants also noted a lack of trained personnel and basic materials. Some providers found their way around these gaps by facilitating informal information exchanges among providers to ensure women were not lost to follow-up.
Conclusions UNASSIGNED
PPC relied on these findings and other data from INSPIRE Phase 1 to implement a HPV-based screen-and-treat program that dramatically increased screening and treatment; however, challenges remain regarding resources and sustainability related to HPV technology.

Identifiants

pubmed: 39399675
doi: 10.21203/rs.3.rs-4992569/v1
pmc: PMC11469402
pii:
doi:

Types de publication

Journal Article Preprint

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R01 CA190366
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA190366
Pays : United States

Déclaration de conflit d'intérêts

Competing Interests The authors declare that they have no other competing interests. PEG and VPS, on behalf of the Proyecto Precancer, received discounted prices and/or donated supplies from Copan and Cepheid.

Auteurs

Lauren Nussbaum (L)

Tulane University School of Public Health and Tropical Medicine.

Joanna Brown (J)

Asociación Benéfica PRISMA.

Graciela Meza-Sánchez (G)

Universidad Nacional de la Amazonía Peruana.

Sandra Soto (S)

Asociación Benéfica PRISMA.

Magdalena Jurczuk (M)

Tulane University School of Public Health and Tropical Medicine.

Javier Vásquez Vásquez (JV)

Universidad Nacional de la Amazonía Peruana.

Henrry Daza Grandez (HD)

Gerencia Regional de Salud.

Lita E Carrillo Jara (LEC)

Gerencia Regional de Salud.

Renso López Liñán (RL)

Universidad Nacional de la Amazonía Peruana.

Patti E Gravitt (PE)

National Cancer Institute, National Institutes of Health.

Valerie A Paz-Soldán (VA)

Tulane University School of Public Health and Tropical Medicine.

Classifications MeSH